Stock Ticker

  • Loading stock data...

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) Presents Interesting Picture as a Bite-Size Buyout Candidate

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) is in an interesting phase of its existence. The company just solidified its sense of credibility in the space with a recent announcement of a productive meeting with top staffing scientists at the host hospital of the Company’s upcoming Phase 2 trial of ProscaVax for prostate cancer. That represents the first […]

Eli Lilly & Co. (NYSE:LLY): Strong Product and Cost Cutting Lead To Better Earnings

Boston, MA 10/31/2013 (wallstreetpr) –¬†Eli Lilly & Co. (NYSE:LLY) new strategy helped the company to raised better earnings than was expected by Wall Street. The two major components of this result was cost cutting and growth of a strong drug for depression, diabetes, and cancer. The company earned $1.20 million, or $1.11 per share, that […]